Announcements Trials
Browse Landscape

Status

Completed 4

Sponsor Class

INDUSTRY 22OTHER 4

Study Type

Interventional 231Observational 4

Sponsor

Cancer Type

Genitourinary 3

Conditions

Carcinoma, Renal Cell 3Neoplasms 1Hypertension 1

Interventions

Surveys and Questionnaires 529Blood Specimen Collection 406Surgical Procedures, Operative 152Radiotherapy 131Interviews as Topic 131Drug Therapy 123Observation 122Magnetic Resonance Spectroscopy 104Biopsy 103Specimen Handling 70Data Collection 70Neoadjuvant Therapy 65Immunohistochemistry 64Magnetic Resonance Imaging 61Immune Checkpoint Inhibitors 59Watchful Waiting 52Immunotherapy 51Bevacizumab 50Positron Emission Tomography Computed Tomography 46Ultrasonography 44Hematologic Tests 42Liquid Biopsy 41Tomography, X-Ray Computed 40Therapeutics 40Radiosurgery 40Colonoscopy 40pembrolizumab 37Hepatectomy 37Gene Expression Profiling 36High-Energy Shock Waves 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Observational × Sunitinib × Clear all
NCT04368546 2021-01-27

Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)

Charite University, Berlin, Germany

Completed
6 enrolled

Hypertension

NCT03519542 2019-09-18

SOGANG

Spanish Oncology Genito-Urinary Group

Completed
62 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT01026337 2019-06-25

Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer

Abramson Cancer Center at Penn Medicine

Completed
43 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00980213 2014-02-06

Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland

Tampere University Hospital

Completed
80 enrolled
Genitourinary

Carcinoma, Renal Cell, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡